Entrada Therapeutics Inc
TRDA
NASDAQ
Biotechnology
$7.46
USD
+0.01 (+0.13%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $290.08M
Volume 238.0K
Price Target
$17.00 – $17.00
USD
The 1 analysts offering 1-year price forecasts have a max estimate of $17.00 and a min estimate of $17.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$17.00
-$4.5 vs prior
Implied Upside
+127.9%
-60.3% vs prior
Analyst Covering
1
-1 vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
33%
Many ratings are older - consensus may be less current
Analyst Agreement
High
Targets are closely clustered - analysts agree more than usual
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
1 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
1 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Debjit Chattopadhyay | Guggenheim | Buy | Maintained | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
SION
Sionna Therapeutics Inc
$6.46
▼ -1.2%
AVXL
Anavex Life Sciences Corp
$3.22
▼ -1.5%
ANIK
Anika Therapeutics Inc
$21.50
▲ +1.6%
SRZN
Surrozen Inc
$23.96
▲ +1.0%
MYGN
Myriad Genetics Inc
$3.03
▼ -4.4%
RNAC
Cartesian Therapeutics Inc
$8.84
▲ +1.4%
ALXO
ALX Oncology Holdings Inc
$1.96
▲ +1.0%
ZSQR
Z Squared Inc (Delaware)
$3.94
▼ -5.3%
ELDN
Eledon Pharmaceuticals Inc
$3.54
▼ -4.3%